Skip to content

The Effects of One Day of Activity on the Next Day's Exercise Response

A Single Day of Inactivity on the Systemic Metabolic and Inflammatory Exercise Response

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07429370
Enrollment
6
Registered
2026-02-24
Start date
2026-01-01
Completion date
2026-12-31
Last updated
2026-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inactivity, Physical

Keywords

Exercise, Metabolism

Brief summary

Exercise can reduce the risk of several chronic diseases. However, recent studies have suggested sitting for too long before exercising can decrease exercise benefits. This study will help determine why this may occur.

Detailed description

Previous work demonstrated a greater utilization of carbohydrates (CHO) at the end of aerobic exercise with a day of reduced activity (\<5,000 steps). Additionally, there are differences in the RNA profile at rest and during exercise in pathways related to inflammation, metabolism, and innate immunity that warrant further research. Together, these data highlight that a single day of reduced activity alters systemic homeostasis that affects the exercise response. Given the potency of exercise to ameliorate risk of cardiovascular disease, more research is needed to find factors to augment the exercise response. Therefore, this study has two goals: 1) Analyze circulating metabolomics, and 2) metabolomics and proteomics in response to exercise after a day of reduced activity.

Interventions

BEHAVIORALDecreased step count

Subjects will walk less than 5,000 steps

Sponsors

Concordia University Wisconsin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* • between the ages of 18-30 years old

Exclusion criteria

* • free from acute or chronic illness (cardiac, pulmonary, liver, or kidney abnormalities, cancer, uncontrolled hypertension, insulin- or non-insulin dependent diabetes or other known metabolic disorders) * do not take medications related to metabolism (i.e., statins, metformin, GLP-1 agonists) * free from orthopedic limitations (including any artificial joints) * currently smoke or participate in other forms of tobacco use.

Design outcomes

Primary

MeasureTime frameDescription
Concentration of metabolites within the plasmaParticipants will complete the study within 6 weeks of enrollment.We will collect blood before and immediately after exercise. Plasma will be separated and sent for untargeted metabolomic analysis.
Concentration of proteins within the plasmaParticipants will complete the study within 6 weeks of enrollment.We will collect blood before and immediately after exercise. Plasma will be separated and sent for untargeted proteomic analysis.

Countries

United States

Contacts

CONTACTKevin J Gries, PhD
kevin.gries@cuw.edu2622434293

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026